Abstracts cont. Clinical Microbiology and Infection

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Staphylococcus aureus in former Portuguese colonies from Africa and the Far East: missing data to help fill the world map  T. Conceição, C. Coelho, I.
Defining an extended-spectrum β-lactamase
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Defining an extended-spectrum β-lactamase
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Quinolone resistance among Shigella spp
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Public health significance of invasive mosquitoes in Europe
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with.
Training for the infectious diseases speciality in Norway
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Bacterial resistance—the clinical challenge
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Elements of design: the knowledge on which we build
Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product  T.G. Bromage  Clinical Microbiology.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Abstracts cont. Clinical Microbiology and Infection
P.M. Hawkey  Clinical Microbiology and Infection 
Current experience in treating invasive zygomycosis with posaconazole
Antimicrobial drug development – the past, the present, and the future
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Abstracts Clinical Microbiology and Infection
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Abstracts cont. Clinical Microbiology and Infection   Clinical Microbiology and Infection  Volume 11, Pages 391-545 (January 2005) DOI: 10.1111/j.1469-0691.2005.clm_1134_03.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

AMPL/SU: ampicillin/sulbactam, CTAX cefotaxine, CTAZ: ceftazidime, CEPI: cefepime, AMK: amikacin, CIPX ciprofloxacin, PIPC/TZ: piperacillin/tazobactam, CPER/SU: cefoperazone/sulbactam, IMIP:imipenem. Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

AMPI/SU: ampicillin/sulbactam, TMP/SMX: trimethoprim/sulphamethoxazole, METC: methicillin, GEN: gentamicin, VAN: vancomycin, CLI: clindamycin, CTIN: cefalothin Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Bactericidal effect of ciprofloxacin in presence of chloramphenicol (mean of 10 different experiments) Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Bacteriostatic effect afnalidixic acid in presence of cho-loromphenicol (mean of 10 different experiments) Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2005 11, 391-545DOI: (10. 1111/j Clinical Microbiology and Infection 2005 11, 391-545DOI: (10.1111/j.1469-0691.2005.clm_1134_03.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.